Market Cap 56.73B
Revenue (ttm) 3.90B
Net Income (ttm) 887.87M
EPS (ttm) N/A
PE Ratio 56.62
Forward PE 49.51
Profit Margin 22.78%
Debt to Equity Ratio 0.34
Volume 532,116
Avg Vol 547,250
Day's Range N/A - N/A
Shares Out 79.85M
Stochastic %K 76%
Beta 1.67
Analysts Strong Sell
Price Target $790.67

Company Profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test ki...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 207 556 0300
Fax: 207 556 4346
Address:
One IDEXX Drive, Westbrook, United States
TheRealShortSqueezy
TheRealShortSqueezy Jan. 14 at 2:30 PM
$PETV Just Dropped News 📰 Digital Landia’s AgenticPet surpassed 1,000+ active beta users in under 72 hours, signaling strong demand for AI-powered preventive pet healthcare. Key highlights: 🔸1,000+ beta users onboarded under 72 hours 🔸 Confirms demand for proactive, AI-driven pet health monitoring 🔸 Powered by 10 specialized AI agents (Veterinarian, Behaviorist, Geneticist, Radiologist, etc.) 🔸 Early users report detection of health, stress, and behavioral issues previously unnoticed 🔸 Backed by an exclusive 10-year partnership with PetVivo Holdings 🔸 Partnership provides access to ~8,500 veterinary clinics nationwide Momentum is building and PETV sits at the center of AI-driven preventive pet care. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 14 at 2:11 AM
$IDXX Share Price: $713.80 Contract Selected: Jul 17, 2026 $710 Calls Buy Zone: $66.47 – $82.11 Target Zone: $115.01 – $140.56 Potential Upside: 63% ROI Time to Expiration: 184 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
SPYmyQQQ
SPYmyQQQ Jan. 13 at 8:17 PM
🎯 Target Hit 🏁 📨 From Dec 9, 2025 🏛️ $IDXX 💵 Entry: $705.0400 ✅ Exit: $725.6272 💰 P/L: +2.92% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
Jblack500
Jblack500 Jan. 13 at 1:32 AM
@WAJeff @cynicaloptimist @FannyPackin @osubuckeye @Clargy @MaverikIT ceo interview at jpm of $ELAN... 6 blockbusters in 2 years...another animal health chart to keep on your radar (no position currently)...$IDXX https://finance.yahoo.com/video/elanco-ceo-gaining-market-share-235414556.html
2 · Reply
ZomedicaPharm
ZomedicaPharm Jan. 9 at 5:38 PM
0 · Reply
Funxs
Funxs Jan. 9 at 4:22 PM
$ZOMDF 3yrs of institutional‘s getting washed out as a reverse splits didn’t get approved then the final death knell was the the listing which forced institutions out and then you had retail tax loss selling in December and the stock really didn’t even go down. It’s more than washed out. insiders bought as high as $.19 and they wouldn’t do that unless they thought this was going to $.60 +. All why the company keeps on improving a single assay on the true form a platform EACTH is an 80 million market opportunity that they’re just getting started and there’s no real competitor that can do it real time even IDXX can’t do this . That’s the reason why $IDXX covectrus heska executives have join this company . Did I mention their $QRVO technology and possible human applications as well. This should be above where lol the insiders bought
0 · Reply
kshonstocks
kshonstocks Jan. 7 at 5:19 PM
$IDXX 95 comp and great chart pattern https://research.investors.com/stock-quotes/nasdaq-idexx-laboratories-idxx.htm
0 · Reply
ZacksResearch
ZacksResearch Jan. 7 at 11:26 AM
$IDXX is quietly crushing it — up 64.7% in a year. 🚀 What’s driving this kind of move? CAG Diagnostics momentum, strong customer retention, and expanding software adoption are fueling growth across regions — a powerful combo that keeps compounding. See what’s powering IDXX’s run and what it means going forward 👉 https://www.zacks.com/stock/news/2813155/idexx-stock-up-647-in-a-year-whats-driving-the-growth?cid=sm-stocktwits-2-2813155-teaser-27674&ADID=SYND_STOCKTWITS_TWEET_2_2813155_TEASER_27674
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jan. 6 at 2:35 PM
$PETV : From Vet Devices to AI Powerhouse 🐾 PetVivo Holdings develops FDA approved regenerative veterinary devices and is now leveraging its installed base to launch a high-margin AI diagnostic platform. The foundation➡️ The Device Business: ➖ SPRYNG & PrecisePRP FDA-approved regenerative veterinary devices ➖1,000+ veterinary clinics actively using PetVivo products ➖7,300+ veterinarians in the distribution network ➖30% gross margins with stable, repeat revenue The Catalyst ➡️The AI Platform: ➖ http://PetVivo.ai launching Q1 2026 (≈ 90 days away) ➖ 10 specialized AI diagnostic agents ➖ 80–90% gross margins, a massive step-change from devices The market opportunity: Wall Street is valuing PetVivo as a low multiple veterinary device company (~$45M market cap), while the company is evolving into an AI-driven platform that could justify a $360M$1.35B+ valuation. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC
1 · Reply
iTrade_Price
iTrade_Price Jan. 6 at 2:14 PM
$IDXX - at support .
0 · Reply
Latest News on IDXX
MoneyShow's Best Investment Ideas For 2026: Part 5

Jan 15, 2026, 12:30 PM EST - 1 day ago

MoneyShow's Best Investment Ideas For 2026: Part 5

HRL HUT IONQ KDK MNKD


IDEXX Announces CEO Succession

Jan 13, 2026, 8:30 AM EST - 3 days ago

IDEXX Announces CEO Succession


IDEXX Laboratories Vs ResMed: Which Stock Could Rally?

Nov 24, 2025, 2:15 PM EST - 7 weeks ago

IDEXX Laboratories Vs ResMed: Which Stock Could Rally?

RMD


Baron Asset Fund Q3 2025 Performance Review

Nov 13, 2025, 2:30 AM EST - 2 months ago

Baron Asset Fund Q3 2025 Performance Review

APH CHH FDS IT MORN ONON STUB


Final Trades: Meta, S&P Global and Idexx Lab

Nov 3, 2025, 1:29 PM EST - 2 months ago

Final Trades: Meta, S&P Global and Idexx Lab

META SPGI


IDEXX Laboratories, Inc. (IDXX) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 11:36 AM EST - 2 months ago

IDEXX Laboratories, Inc. (IDXX) Q3 2025 Earnings Call Transcript


Idexx Stock Pops on Earnings. Pet Health Is Booming.

Nov 3, 2025, 11:08 AM EST - 2 months ago

Idexx Stock Pops on Earnings. Pet Health Is Booming.


IDEXX Laboratories Announces Third Quarter Results

Nov 3, 2025, 6:30 AM EST - 2 months ago

IDEXX Laboratories Announces Third Quarter Results


IDEXX Laboratories Elects Karen Peacock to Board of Directors

Oct 7, 2025, 7:00 AM EDT - 3 months ago

IDEXX Laboratories Elects Karen Peacock to Board of Directors


IDEXX Laboratories Announces Second Quarter Results

Aug 4, 2025, 6:30 AM EDT - 5 months ago

IDEXX Laboratories Announces Second Quarter Results


IDEXX Laboratories: A Business With Strong Fundamentals

Jul 17, 2025, 7:06 AM EDT - 6 months ago

IDEXX Laboratories: A Business With Strong Fundamentals


IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits

May 14, 2025, 2:35 PM EDT - 8 months ago

IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits


IDEXX Laboratories Announces First Quarter Results

May 1, 2025, 6:30 AM EDT - 9 months ago

IDEXX Laboratories Announces First Quarter Results


IDEXX Laboratories: A Top Dog In The Pet Care Market

Mar 12, 2025, 6:24 AM EDT - 11 months ago

IDEXX Laboratories: A Top Dog In The Pet Care Market


IDEXX Laboratories And Its Real Value

Feb 10, 2025, 11:27 AM EST - 1 year ago

IDEXX Laboratories And Its Real Value


TheRealShortSqueezy
TheRealShortSqueezy Jan. 14 at 2:30 PM
$PETV Just Dropped News 📰 Digital Landia’s AgenticPet surpassed 1,000+ active beta users in under 72 hours, signaling strong demand for AI-powered preventive pet healthcare. Key highlights: 🔸1,000+ beta users onboarded under 72 hours 🔸 Confirms demand for proactive, AI-driven pet health monitoring 🔸 Powered by 10 specialized AI agents (Veterinarian, Behaviorist, Geneticist, Radiologist, etc.) 🔸 Early users report detection of health, stress, and behavioral issues previously unnoticed 🔸 Backed by an exclusive 10-year partnership with PetVivo Holdings 🔸 Partnership provides access to ~8,500 veterinary clinics nationwide Momentum is building and PETV sits at the center of AI-driven preventive pet care. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 14 at 2:11 AM
$IDXX Share Price: $713.80 Contract Selected: Jul 17, 2026 $710 Calls Buy Zone: $66.47 – $82.11 Target Zone: $115.01 – $140.56 Potential Upside: 63% ROI Time to Expiration: 184 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
SPYmyQQQ
SPYmyQQQ Jan. 13 at 8:17 PM
🎯 Target Hit 🏁 📨 From Dec 9, 2025 🏛️ $IDXX 💵 Entry: $705.0400 ✅ Exit: $725.6272 💰 P/L: +2.92% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
Jblack500
Jblack500 Jan. 13 at 1:32 AM
@WAJeff @cynicaloptimist @FannyPackin @osubuckeye @Clargy @MaverikIT ceo interview at jpm of $ELAN... 6 blockbusters in 2 years...another animal health chart to keep on your radar (no position currently)...$IDXX https://finance.yahoo.com/video/elanco-ceo-gaining-market-share-235414556.html
2 · Reply
ZomedicaPharm
ZomedicaPharm Jan. 9 at 5:38 PM
0 · Reply
Funxs
Funxs Jan. 9 at 4:22 PM
$ZOMDF 3yrs of institutional‘s getting washed out as a reverse splits didn’t get approved then the final death knell was the the listing which forced institutions out and then you had retail tax loss selling in December and the stock really didn’t even go down. It’s more than washed out. insiders bought as high as $.19 and they wouldn’t do that unless they thought this was going to $.60 +. All why the company keeps on improving a single assay on the true form a platform EACTH is an 80 million market opportunity that they’re just getting started and there’s no real competitor that can do it real time even IDXX can’t do this . That’s the reason why $IDXX covectrus heska executives have join this company . Did I mention their $QRVO technology and possible human applications as well. This should be above where lol the insiders bought
0 · Reply
kshonstocks
kshonstocks Jan. 7 at 5:19 PM
$IDXX 95 comp and great chart pattern https://research.investors.com/stock-quotes/nasdaq-idexx-laboratories-idxx.htm
0 · Reply
ZacksResearch
ZacksResearch Jan. 7 at 11:26 AM
$IDXX is quietly crushing it — up 64.7% in a year. 🚀 What’s driving this kind of move? CAG Diagnostics momentum, strong customer retention, and expanding software adoption are fueling growth across regions — a powerful combo that keeps compounding. See what’s powering IDXX’s run and what it means going forward 👉 https://www.zacks.com/stock/news/2813155/idexx-stock-up-647-in-a-year-whats-driving-the-growth?cid=sm-stocktwits-2-2813155-teaser-27674&ADID=SYND_STOCKTWITS_TWEET_2_2813155_TEASER_27674
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jan. 6 at 2:35 PM
$PETV : From Vet Devices to AI Powerhouse 🐾 PetVivo Holdings develops FDA approved regenerative veterinary devices and is now leveraging its installed base to launch a high-margin AI diagnostic platform. The foundation➡️ The Device Business: ➖ SPRYNG & PrecisePRP FDA-approved regenerative veterinary devices ➖1,000+ veterinary clinics actively using PetVivo products ➖7,300+ veterinarians in the distribution network ➖30% gross margins with stable, repeat revenue The Catalyst ➡️The AI Platform: ➖ http://PetVivo.ai launching Q1 2026 (≈ 90 days away) ➖ 10 specialized AI diagnostic agents ➖ 80–90% gross margins, a massive step-change from devices The market opportunity: Wall Street is valuing PetVivo as a low multiple veterinary device company (~$45M market cap), while the company is evolving into an AI-driven platform that could justify a $360M$1.35B+ valuation. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC
1 · Reply
iTrade_Price
iTrade_Price Jan. 6 at 2:14 PM
$IDXX - at support .
0 · Reply
Thelonius_Stonk
Thelonius_Stonk Jan. 6 at 2:38 AM
$IDXX 👌
1 · Reply
BillionerOfKing
BillionerOfKing Jan. 2 at 6:53 PM
$IDXX Current Stock Price: $664.00 Contracts to trade: $660 IDXX Jan 16 2026 Call Entry: $13.90 Exit: $24.72 ROI: 78% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
ZacksResearch
ZacksResearch Jan. 1 at 6:00 AM
Looking for ESG winners with real return potential into 2026? 🌱📈 $NVDA, $IDXX and $MSFT stand out on ESG metrics, combining strong performance with ambitious 2030 goals that are keeping investor interest high. Want to see why these ESG names make the cut? Full breakdown here 👉 https://www.zacks.com/stock/news/2810466/3-esg-stocks-to-add-to-your-portfolio-for-sustainable-returns-in-2026?cid=sm-stocktwits-2-2810466-teaser-26868&ADID=SYND_STOCKTWITS_TWEET_2_2810466_TEASER_26868
2 · Reply
WaverVanir
WaverVanir Dec. 31 at 1:52 PM
0 · Reply
ZacksResearch
ZacksResearch Dec. 30 at 5:39 PM
ESG investing spotlight: Why $NVDA, $IDXX, and $MSFT are top picks for 2026! 🌍 🤖 NVIDIA aims for 50% reduction in emissions by 2030 and shows 36.9% share appreciation over the past year. 🐾 IDEXX Laboratories strengthens green initiatives with a 66% share surge and steady earnings growth forecast. 💧 Microsoft targets carbon negative and water positive by 2030, with a 14.7% stock return this past year. Discover the full ESG investment case here 👉 https://www.zacks.com/stock/news/2810466/3-esg-stocks-to-add-to-your-portfolio-for-sustainable-returns-in-2026?cid=sm-stocktwits-2-2810466-body-26866&ADID=SYND_STOCKTWITS_TWEET_2_2810466_BODY_26866
0 · Reply
TribbleTrader
TribbleTrader Dec. 24 at 6:38 PM
$IDXX Future valuation dynamics revolve around execution consistency across macro cycles and demand regimes, with outcomes shaped by timing and discipline. Execution clarity would stabilize long‑term sentiment.
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 18 at 9:48 AM
$IDXX Current Stock Price: $695.54 Contracts to trade: $700 IDXX Dec 19 2025 Call Entry: $3.34 Exit: $5.39 ROI: 61% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
ZacksResearch
ZacksResearch Dec. 15 at 12:58 PM
MedTech stocks to watch in 2026: $ISRG, $PODD, $BSX, $IDXX 🚀 🦾 ISRG: Da Vinci systems drive expected 14.3% revenue growth in 2026, Zacks Rank #1 📈 PODD: Omnipod 5 expansion fuels 19.8% revenue boost, Zacks Rank #2 💉 BSX: WATCHMAN & FARAPULSE tech gain traction, Zacks Rank #2 🐾 IDXX: Companion Animal diagnostics thrive, Zacks Rank #2 Discover why these could outperform 👉 https://www.zacks.com/stock/news/2804170/4-medical-device-stocks-to-buy-for-healthy-returns-in-2026?cid=sm-stocktwits-2-2804170-body-24744&ADID=SYND_STOCKTWITS_TWEET_2_2804170_BODY_24744
0 · Reply
ZacksResearch
ZacksResearch Dec. 15 at 11:58 AM
Medtech’s next growth wave is taking shape — and these names are leading it 🚀 $ISRG, $PODD, $BSX and $IDXX are highlighted as leaders in medtech innovation, leveraging AI, robotics, and diagnostics as key growth drivers heading into 2026. See how each company is positioned to benefit from these technologies 👉 https://www.zacks.com/stock/news/2804170/4-medical-device-stocks-to-buy-for-healthy-returns-in-2026?cid=sm-stocktwits-2-2804170-teaser-24735&ADID=SYND_STOCKTWITS_TWEET_2_2804170_TEASER_24735
0 · Reply
Roberto24
Roberto24 Dec. 12 at 1:19 AM
0 · Reply
Roberto24
Roberto24 Dec. 12 at 12:59 AM
0 · Reply
JarvisFlow
JarvisFlow Dec. 9 at 2:53 PM
Barclays updates rating for IDEXX Laboratories ( $IDXX ) to Overweight, target set at 850.
0 · Reply